James M. Inhofe bought Intellia Therapeutics Inc (NASDAQ: NTLA)
James M. Inhofe (R-OK), a U.S. Senator, has disclosed 2 trades in Intellia Therapeutics Inc (NTLA) since 2017, 1 purchase and 1 sale, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James M. Inhofe bought $15,001 - $50,000 of Intellia Therapeutics Inc (NASDAQ: NTLA) on October 19, 2017. Since that trade, NTLA is down -61.50% against the S&P 500 up +225.67%, an outperformance of -287.17%.
Across these filings, James M. Inhofe has been a balanced trader of NTLA (a buy-to-sell ratio of 1.00). The most recent disclosed NTLA transaction shown was dated October 25, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James M. Inhofe's NTLA trades vs the price
NTLA is down -61.50% since James M. Inhofe bought on October 19, 2017, versus +225.67% for the S&P 500.
Performance since this trade
All James M. Inhofe NTLA trades
James M. Inhofe & NTLA trading FAQ
Is it legal for James M. Inhofe to trade Intellia Therapeutics Inc (NTLA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Intellia Therapeutics Inc (NTLA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James M. Inhofe buy NTLA?
James M. Inhofe disclosed a purchase of $15,001 - $50,000 of Intellia Therapeutics Inc (NTLA) on October 19, 2017, according to public STOCK Act filings.
How has NTLA performed since James M. Inhofe's trade?
Since James M. Inhofe bought NTLA on October 19, 2017, the stock is down -61.50%, versus +225.67% for the S&P 500 over the same period, an outperformance of -287.17%.
How many times has James M. Inhofe traded NTLA?
James M. Inhofe has disclosed 2 NTLA trades since 2017 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NTLA trades?
Quantellect tracks every disclosed congressional trade in Intellia Therapeutics Inc (NTLA) on the Intellia Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
James M. Inhofe's NTLA tradesAll congressional filings for Intellia Therapeutics IncJames M. Inhofe's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.